We offer a combination of:
Through established relationships with cardiac societies, clinicians, and healthcare institutions, we provide direct access to diverse healthcare settings across the continent.
We design and deliver structured programs, including:
We understand the realities of African healthcare systems and align programs with global standards, ensuring both relevance and scalability.
Our programs are designed to deliver clear outcomes, including:
We work with partners through flexible and structured engagement models:

Co-develop and implement CPD-accredited programs to improve awareness and diagnosis among healthcare providers.

Design and execute research initiatives, including surveys, registries, and real-world data studies across multiple sites.

Develop and implement initiatives focused on improving diagnostic pathways, referral systems, and patient care.

Scale programs across African countries through coordinated partnerships with local institutions and societies.

Support validation and implementation of AI-driven diagnostic tools in real-world African settings.
We collaborate with organizations that share a commitment to improving healthcare outcomes: Pharmaceutical and life sciences companies, MedTech and AI developers, Non-governmental organizations (NGOs), Academic and research institutions, Healthcare providers and hospital networks, Regional and national cardiac societies
Partnering with Amyloidosis Africa provides:
We focus on building long-term, strategic partnerships that are:
Cardiac amyloidosis is often diagnosed too late across Africa. Together, we can change that.
Support early diagnosis, clinician education, and life-saving research. Your contribution helps us reach underserved communities, train healthcare providers, and improve access to care across Africa.
We deliver evidence-based medical education to healthcare professionals across Africa to strengthen early diagnosis and improve patient outcomes.
We connect researchers and clinicians across Africa to collaborate on amyloidosis research, share data, and strengthen multicenter African-led studies.
We advocate for the recognition of amyloidosis as a health priority in Africa, promoting equitable access to diagnosis, care, and policy support.
We raise awareness of amyloidosis across Africa to improve early recognition, reduce misdiagnosis, and challenge the myth that the disease is rare.
We advance Africa-led clinical research to improve understanding, diagnosis, and outcomes of amyloidosis, ensuring African patients are represented in global evidence.
We implement quality improvement initiatives to reduce diagnostic delays, improve clinical pathways, and strengthen amyloidosis care within African health systems.
We support patients and families by improving access to reliable information, guidance, and navigation throughout the amyloidosis care journey.
We advance cardiac amyloidosis care across Africa through collaboration, training, and research. Join us to change the future of heart health and empower local clinicians with knowledge and tools.